missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CD45 Antibody (5C16) - Azide and BSA Free, Novus Biologicals™
Rat Monoclonal Antibody has been used in 7 publications
Brand: Novus Biologicals NB110-93609
This item is not returnable.
View return policy
Description
CD45 Monoclonal specifically detects CD45 in Mouse samples. It is validated for Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin.
Specifications
| CD45 | |
| Monoclonal | |
| LYOPH | |
| Immunohistochemistry 1:10-1:500, Immunocytochemistry/Immunofluorescence 1:10-1:500, Immunoprecipitation 1:100, Immunohistochemistry-Paraffin 1:100-1:400 | |
| P06800 | |
| PTPRC | |
| Cell lysates of mouse leukocytes | |
| 0.1 mg | |
| Adaptive Immunity, Cell Biology, Cellular Markers, Hematopoietic Stem Cell Markers, Immunology, Innate Immunity, Mesenchymal Stem Cell Markers, Microglia Markers, Neuronal Cell Markers, Neuroscience, Signal Transduction, Stem Cell Markers | |
| 5788 | |
| Reconstitute with 0.5 ml sterilized PBS to a final concentration of 0.2 mg/ml. | |
| Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. | |
| IgG2 |
| Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin) | |
| 5C16 | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS. 0.025 mg size is provided in liquid form, PBS with No Preservative | |
| B220, CD45 antigen, CD45R, EC 3.1.3.48, L-CA, LY5, protein tyrosine phosphatase, receptor type, C, receptor-type tyrosine-protein phosphatase C, T200 glycoprotein, T200 leukocyte common antigen, T200receptor type, c polypeptide | |
| Rat | |
| Protein A or G purified | |
| RUO | |
| Primary | |
| This was selected for its ability to detect mouse CD45 positive leukocytes in IHC. | |
| Mouse | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction